InterMune
NASDAQ:ITMN
$14.68
-$0.73
(-4.74%)
Quote as of 2:06 PM EST on 02/10/12
|
$14.68
|
|
| Today's Open | $15.15 |
|---|---|
| Previous Close | $15.41 |
| Daily Range | $14.48 - $15.50 |
| 52-Week Range | $10.67 - $51.71 |
| Market Cap | $961.65M |
| P/E Ratio | -5.97 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 1,147,128 |
| Average Daily Volume | 2,374,260 |
| Current FY EPS | -$2.59 |
ITMN Information
| Description |
|---|
| The Company is a biotech company focused on developing and commercializing innovative therapies in pulmonology and hepatology. |
| Sector |
| Healthcare |
| Industry |
| Biotechnology |
News & Commentary
InterMune Widens Loss, Sales Dip - Analyst Blog
3 Lessons From the J.P. Morgan Health-Care Confab
The 2 Biotechs Ramping Up Sales
InterMune 4Q Esbriet Sales Snapshot - Analyst Blog
InterMune Shares Popped: What You Need to Know
Are These Biotech Drug Launches Back on Track?
3 Stock-Moving Binary Events to Watch in 2012
The Worst Health Care Stocks of 2011
